Search

Accuray Inc

Закрыт

СекторЗдравоохранение

0.27 -12.9

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

0.28

Макс.

0.31

Ключевые показатели

By Trading Economics

Доход

2M

-12M

Продажи

2.6M

105M

Прибыль на акцию

-0.07

Рентабельность продаж

-11.259

Сотрудники

990

EBITDA

2.5M

-813K

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+12.9% upside

Дивиденды

By Acuity

Следующий отчет о доходах

12 авг. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-22M

32M

Предыдущая цена открытия

13.17

Предыдущая цена закрытия

0.27

Новостные настроения

By Acuity

50%

50%

175 / 340 Рейтинг в Healthcare

Accuray Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

4 авг. 2026 г., 20:02 UTC

Accuray Inc shares are higher today amid positive market sentiment and declining crude oil prices. Comments on potential peace talks with Iran also support the move.

3 авг. 2026 г., 19:31 UTC

Accuray Inc shares are lower today, with no specific news identified to explain the decline, despite broader market gains.

31 июл. 2026 г., 23:16 UTC

Accuray Inc shares are lower in after-market trading, with no specific news identified. Broader market pressures also impacted other tech companies, including Apple Inc.

30 июл. 2026 г., 23:51 UTC

Accuray Inc shares are lower in after-market hours, with no specific news identified for the decline. Broader market conditions remain mixed amid geopolitical concerns.

29 июл. 2026 г., 23:02 UTC

News

Accuray Inc. announced a $40 million debt exchange and $15 million equity investment to enhance its financial position, with shares trading higher after market close.

28 июл. 2026 г., 23:16 UTC

Accuray Inc shares are trading lower in after-market hours, reflecting broader market pressures in the technology sector amid concerns over AI spending and competition.

27 июл. 2026 г., 19:32 UTC

Accuray Inc's shares are declining today, hitting a low after an early high. Broader market conditions, including falling oil prices, may be influencing sentiment.

24 июл. 2026 г., 19:11 UTC

Accuray Inc's shares are higher today, driven by gains in the Health Care Equipment sub-sector. The stock remains near its one-month low.

22 июл. 2026 г., 18:51 UTC

Accuray Inc. shares are trading flat, remaining 7.82% below their 20-day moving average amid a lack of upward momentum.

20 июл. 2026 г., 19:31 UTC

Accuray Inc shares are lower today, diverging from a recent trend of higher closes. Broader market dynamics may be impacting investor sentiment.

Сравнение c конкурентами

Изменение цены

Accuray Inc Прогноз

Целевая цена

By TipRanks

12.9% рост

Прогноз на 12 месяцев

Средняя 0.35 USD  12.9%

Максимум 0.35 USD

Минимум 0.35 USD

Основано на мнении 1 аналитиков Wall Street, спрогнозировавших целевые цены для Accuray Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

1 ratings

0

Покупка

1

Удержание

0

Продажа

Настроения

By Acuity

175 / 340Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
help-icon Live chat